Khiron Pharma ApS: Financial statements 2017
CVR: 37002984
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Khiron Pharma ApS (CVR 37002984) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK 22,094. Equity in the 2017 report amounted to DKK 8,464. The solvency ratio was 25.2%.
- Profit/Loss
- DKK 22,094
- Equity
- DKK 8,464
- Total Assets
- DKK 33,631
- Employees
- 0
Official annual report
Keep an eye on Khiron Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Khiron Pharma ApS has published its interim report for the period August 10, 2015 – December 31, 2016.
As of May 24, 2017, TREKRONER REVISION A/S - GODKENDTE REVISORER has stepped down as auditor of Khiron Pharma ApS.
About Khiron Pharma ApS
Khiron Pharma ApS was a Danish company of the type Anpartsselskab based in Fuglebjerg, founded in 2015. The company has been dissolved on 6 December 2021. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -6,501 and a net result of DKK -75,172 compared with DKK 64,014 the year before. Equity in the 2020 report amounted to DKK 7,536.